Molecular Biology of the Cell Sign up for new MBC in Press e-TOCs!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E04-03-0233 on July 14, 2004

Vol. 15, Issue 9, 4299-4309, September 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E04-03-0233v1
15/9/4299    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kansra, S.
Right arrow Articles by Elder, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kansra, S.
Right arrow Articles by Elder, J. T.

Autocrine Extracellular Signal-regulated Kinase (ERK) Activation in Normal Human Keratinocytes: Metalloproteinase-mediated Release of Amphiregulin Triggers Signaling from ErbB1 to ERK

Sanjay Kansra * {dagger} {ddagger} §, Stefan W. Stoll * {dagger}, Jessica L. Johnson *, and James T. Elder * § || ¶

* Departments of Dermatology, University of Michigan Medical Center, Ann Arbor, MI 48109; || Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI 48109; and Ann Arbor Veterans Affairs Health System, Ann Arbor, MI 48105

Submitted March 18, 2004; Revised July 2, 2004; Accepted July 6, 2004
Monitoring Editor: Carl-Henrik Heldin

ErbB signaling through extracellular signal-regulated kinase (ERK) has been implicated in regulating the expression of ErbB ligands in hyperproliferative skin disorders and wound healing. Here, we characterize the process of autocrine ERK activation in cultured normal human keratinocytes (NHKs) subjected to growth factor (GF) deprivation. Basal ERK phosphorylation was lower after 48 h than after 24 h of GF deprivation, and lowest at 30–60 min after an additional medium change. ERK phosphorylation was markedly increased by low concentrations of epidermal growth factor (EGF) (0.2–1 ng/ml) that provoked only a limited increase in ErbB1 tyrosine phosphorylation and internalization. Basal ErbB tyrosine phosphorylation and ERK phosphorylation were inhibited by two different ErbB receptor tyrosine kinase inhibitors, by the ErbB1-specific neutralizing monoclonal antibody 225 IgG, by two different metalloproteinase inhibitors, and by neutralizing antibodies against amphiregulin (AR). In contrast, these responses were unaffected by neutralizing antibodies against other ErbB1 ligands or the ErbB2 inhibitors geldanamycin and AG825. The time course of autocrine ERK phosphorylation correlated with the appearance of soluble AR, and two different metalloproteinase inhibitors blocked AR release. These results define an amphiregulin- and ErbB1-dependent mechanism by which autocrine ERK activation is maintained in NHKs, even when ErbB1 autophosphorylation and internalization are limited.


Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E04–03–0233. Article and publication date are available at www.molbiolcell.org/cgi/doi/10.1091/mbc.E04–03–0233.

{dagger} These authors made equal contributions to this study.

{ddagger} Present address: Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati, 3125 Eden Ave., Cincinnati, OH 45267-0521.

§ Corresponding authors. E-mail addresses: jelder{at}umich.edu; sanjay.kansra{at}uc.edu.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
L. Rittie, S. Kansra, S. W. Stoll, Y. Li, J. E. Gudjonsson, Y. Shao, L. E. Michael, G. J. Fisher, T. M. Johnson, and J. T. Elder
Differential ErbB1 Signaling in Squamous Cell versus Basal Cell Carcinoma of the Skin
Am. J. Pathol., June 1, 2007; 170(6): 2089 - 2099.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Narita, J. Chien, S. A. Mullany, J. Staub, X. Qian, W. L. Lingle, and V. Shridhar
Loss of HSulf-1 Expression Enhances Autocrine Signaling Mediated by Amphiregulin in Breast Cancer
J. Biol. Chem., May 11, 2007; 282(19): 14413 - 14420.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D. L. Russell and R. L. Robker
Molecular mechanisms of ovulation: co-ordination through the cumulus complex
Hum. Reprod. Update, May 1, 2007; 13(3): 289 - 312.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Lipfert, J. E. Fisher, N. Wei, A. Scafonas, Q. Su, J. Yudkovitz, F. Chen, S. Warrier, E. T. Birzin, S. Kim, et al.
Antagonist-Induced, Activation Function-2-Independent Estrogen Receptor {alpha} Phosphorylation
Mol. Endocrinol., March 1, 2006; 20(3): 516 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xu, L.-J. Tan, V. Grachtchouk, J. J. Voorhees, and G. J. Fisher
Receptor-type Protein-tyrosine Phosphatase-{kappa} Regulates Epidermal Growth Factor Receptor Function
J. Biol. Chem., December 30, 2005; 280(52): 42694 - 42700.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Kansra, S. W. Stoll, J. L. Johnson, and J. T. Elder
Src Family Kinase Inhibitors Block Amphiregulin-Mediated Autocrine ErbB Signaling in Normal Human Keratinocytes
Mol. Pharmacol., April 1, 2005; 67(4): 1145 - 1157.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.